Balentine LLC Albemarle Corp Transaction History

Balentine LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$214.02 - $325.38 $14,767 - $22,451	-69 Reduced 6.62%	973 $210,000
Q3 2022 Oct 26, 2022	SELL	$195.82 - $307.05 $83,027 - $130,189	-424 Reduced 28.92%	1,042 $275,000
Q2 2022 Aug 15, 2022	BUY	$187.76 - $270.92 $275,256 - $397,168	1,466 New	1,466 $306,000
Q1 2020 May 18, 2020	SELL	$50.9 - $94.31 $407 - $754	-8 Closed	0 $0
Q4 2019 Sep 02, 2020	SELL	$60.74 - $73.04 $5,831 - $7,011	-96 Reduced 92.31%	8 $1,000
Q3 2019 Nov 15, 2019	BUY	$59.3 - $75.53 $6,167 - $7,855	104 New	104 $7,000
Q1 2018 May 16, 2018	SELL	$89.56 - $137.45 $7,881 - $12,095	-88 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$109.36 - $136.31 $9,623 - $11,995	88	88 $12,000

927

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $10.5B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

Stay updated on Balentine LLC with notifications on news.